One hundred and seventeen subjects with CIDP were randomly assigned to IVIg (Gamunex, n = 59) or placebo (0.1% albumin, n = 58) [27]. This evidence concerns the gene ALB and chronic inflammatory demyelinating polyradiculoneuropathy.